In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...

Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...

Around 30,000 courses of Pfizer’s oral antiviral treatment Paxlovid arrived in Canada last week, with 11,000 of those distributed to Ontario, noted Dr. Andrew Morris, a professor of infectious ...

2:20 Health Canada approves Paxlovid, Pfizer’s COVID-19 pill As Paxlovid has become more widely used, some patients have reported that COVID-19 symptoms recurred after completing treatment and ...

Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...

An antiviral drug being hailed for its potential role in the treatment of COVID-19 is now available in Ontario, but doctors warn it comes with significant challenges including low supply. Around ...

Canada has approved the first oral COVID-19 treatment that can be taken at home: an antiviral drug from Pfizer called Paxlovid. The approval comes as Canada grapples with an Omicron-fueled surge ...

Pfizer, which announced a $3.5 billion cost-cutting program earlier this month, slashed $9 billion off its 2023 sales forecast after agreeing to take back nearly 8 million Paxlovid treatment ...

Pfizer is committed to working toward equitable access to our oral COVID-19 treatment, PAXLOVID, for high-risk patients in need. Pfizer has established a comprehensive strategy in close partnership ...

Pfizer’s clinical trial tested Paxlovid in unvaccinated people who had risk factors for serious disease and found that the two-drug treatment cut the risk of hospitalization and death by 90%.

Use of Pfizer Inc’s COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can ...